Stockreport

NeuroSense Announces First Quarter 2024 Business Update

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerat [Read more]